Bressler NM, Bressler SB, Childs AL, Haller JA, Hawkins BS, Lewis H, et al. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology. 2004;111:1993–2006.

Article  PubMed  Google Scholar 

Shienbaum G, Garcia Filho CAA, Flynn HW, Nunes RP, Smiddy WE, Rosenfeld PJ. Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy. Am J Ophthalmol. 2013;155:1009–13.

Article  CAS  PubMed  Google Scholar 

Kim JH, Chang YS, Kim JW, Kim CG, Yoo SJ, Cho HJ. Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization. Ophthalmology. 2014;121:926–35.

Article  PubMed  Google Scholar 

Stifter E, Michels S, Prager F, Georgopoulos M, Polak K, Hirn C, et al. Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage. Am J Ophthalmol. 2007;144:886–92.

Article  CAS  PubMed  Google Scholar 

Chang MA, Do DV, Bressler SB, Cassard SD, Gower EW, Bressler NM. Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration. Retina. 2010;30:1171–6.

Article  PubMed  Google Scholar 

Iacono P, Parodi MB, Introini U, La Spina C, Varano M, Bandello F. Intravitreal ranibizumab for choroidal neovascularization with large submacular hemorrhage in age-related macular degeneration. Retina. 2014;34:281–7.

Article  CAS  PubMed  Google Scholar 

Stanescu-Segall D, Balta F, Jackson TL. Submacular hemorrhage in neovascular age-related macular degeneration: a synthesis of the literature. Surv Ophthalmol. 2016;61:18–32.

Article  PubMed  Google Scholar 

Sacu S, Stifter E, Vécsei-Marlovits PV, Michels S, Schütze C, Prünte C, et al. Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration. Eye. 2009;23:1404–10.

Article  CAS  PubMed  Google Scholar 

Kim HS, Cho HJ, Yoo SG, Kim JH, Han JI, Lee TG, et al. Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration. Eye. 2015;29:1141–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cho HJ, Koh KM, Kim HS, Lee TG, Kim CG, Kim JW. Anti-vascular endothelial growth factor monotherapy in the treatment of submacular hemorrhage secondary to polypoidal choroidal vasculopathy. Am J Ophthalmol. 2013;156:524–31.e1.

Article  CAS  PubMed  Google Scholar 

Mun Y, Park KH, Park SJ, Cho HJ, Kim CG, Kim JW, et al. Comparison of treatment methods for submacular hemorrhage in neovascular age-related macular degeneration: conservative versus active surgical strategy. Sci Rep. 2022;12:14875.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shin JY, Lee J-M, Byeon SH. Anti-vascular endothelial growth factor with or without pneumatic displacement for submacular hemorrhage. Am J Ophthalmol. 2015;159:904–14.e1.

Article  CAS  PubMed  Google Scholar 

Inoue N, Kato A, Araki T, Kimura T, Kinoshita T, Okamoto F, et al. Visual prognosis of submacular hemorrhage secondary to age-related macular degeneration: a retrospective multicenter survey. PLoS ONE. 2022;17:e0271447.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barayev E., Tiosano A., Zlatkin R., Elul R., Dotan A., Hadayer A. et al.Prognostic factors for visual acuity improvement after treatment of submacular hemorrhage secondary to exudative age-related macular degeneration.Eur J Ophthalmol.2023;34:825–33. https://doi.org/10.1177/11206721231202048.

Article  PubMed  Google Scholar 

Cheung CMG, Bhargava M, Xiang L, Mathur R, Mun CC, Wong D, et al. Six-month visual prognosis in eyes with submacular hemorrhage secondary to age-related macular degeneration or polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol. 2013;251:19–25.

Article  PubMed  Google Scholar 

Cheung CMG, Lai TYY, Teo K, Ruamviboonsuk P, Chen S-J, Kim JE, et al. Polypoidal choroidal vasculopathy: consensus nomenclature and non-indocyanine green angiograph diagnostic criteria from the asia-pacific ocular imaging society PCV workgroup. Ophthalmology. 2021;128:443–52.

Article  PubMed  Google Scholar 

Tan CS, Ngo WK, Chen JP, Tan NW, Lim TH, EVEREST Study group EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. Br J Ophthalmol. 2015;99:624–8.

Article  PubMed  Google Scholar 

Ying G, Maguire MG, Daniel E, Ferris FL, Jaffe GJ, Grunwald JE, et al. Association of baseline characteristics and early vision response with 2-year vision outcomes in the comparison of AMD treatments trials (CATT). Ophthalmology. 2015;122:2523–31.e1.

Article  PubMed  Google Scholar 

Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Maguire MG, Martin DF, Ying G-S, Jaffe GJ, Daniel E, et al. Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2016;123:1751–61.

Article  Google Scholar 

Hochman MA, Seery CM, Zarbin MA. Pathophysiology and management of subretinal hemorrhage. Surv Ophthalmol. 1997;42:195–213.

Article  CAS  PubMed  Google Scholar 

Kim JH, Chang YS, Lee DW, Kim CG, Kim JW. Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy. Jpn J Ophthalmol. 2018;62:54–62.

Article  PubMed  Google Scholar 

Lee K, Park YG, Park YH. Visual prognosis after pneumatic displacement of submacular hemorrhage according to age-related macular degeneration subtypes. Retina. 2020;40:2304–11.

Article  CAS  PubMed  Google Scholar 

Chan WM, Liu DT, Lai TY, Li H, Tong JP, Lam DS. Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up. Clin Exp Ophthalmol. 2005;33:611–8.

Article  PubMed  Google Scholar 

Matsuo Y, Haruta M, Ishibashi Y, Ishibashi K, Furushima K, Kato N, et al. Visual outcomes and prognostic factors of large submacular hemorrhages secondary to polypoidal choroidal vasculopathy. Clin Ophthalmol. 2021;15:3557–62.

Article  PubMed  PubMed Central  Google Scholar 

Hassan AS, Johnson MW, Schneiderman TE, Regillo CD, Tornambe PE, Poliner LS, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 1999;106:1900–6.

Article  CAS  PubMed  Google Scholar 

Jackson TL, Bunce C, Desai R, Hillenkamp J, Lee CN, Lois N, et al. Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to exudative age-related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial. Trials. 2022;23:99.

Article  CAS  PubMed  PubMed Central  Google Scholar